Literature DB >> 3995220

Resin-coated 5-aminosalicylic acid (Asacol) in rheumatoid arthritis.

R D Situnayake, B McConkey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3995220     DOI: 10.1093/rheumatology/24.2.226

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


× No keyword cloud information.
  9 in total

1.  History of the development of sulphasalazine in rheumatology.

Authors:  B McConkey
Journal:  Drugs       Date:  1986       Impact factor: 9.546

2.  Pharmacological studies of antigen-induced arthritis in BALB/c mice. II. The effects of second-line antirheumatic drugs and cytotoxic agents on the histopathological changes.

Authors:  I M Hunneyball; M J Crossley; M Spowage
Journal:  Agents Actions       Date:  1986-06

3.  Which component of sulphasalazine is active in rheumatoid arthritis?

Authors:  R D Situnayake; B McConkey
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-13

4.  Multiple biological activities of human recombinant interleukin 1.

Authors:  C A Dinarello; J G Cannon; J W Mier; H A Bernheim; G LoPreste; D L Lynn; R N Love; A C Webb; P E Auron; R C Reuben
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

5.  Co-trimoxazole in rheumatoid arthritis: a comparison with sulphapyridine.

Authors:  C Astbury; J Hill; H A Bird
Journal:  Ann Rheum Dis       Date:  1988-04       Impact factor: 19.103

6.  Changes in normal glycosylation mechanisms in autoimmune rheumatic disease.

Authors:  J S Axford; N Sumar; A Alavi; D A Isenberg; A Young; K B Bodman; I M Roitt
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

7.  5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?

Authors:  A J Taggart; V C Neumann; J Hill; C Astbury; P Le Gallez; J S Dixon
Journal:  Drugs       Date:  1986       Impact factor: 9.546

8.  Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.

Authors:  R S Amos; T Pullar; D E Bax; D Situnayake; H A Capell; B McConkey
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-16

9.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.